Home

Laboratory Corp American Holdings (LH)

260.32
-7.37 (-2.75%)
NYSE · Last Trade: Jul 25th, 12:13 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earningsbenzinga.com
Via Benzinga · July 25, 2025
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga.com
Via Benzinga · July 25, 2025
10 Analysts Have This To Say About Labcorp Hldgsbenzinga.com
Via Benzinga · July 25, 2025
LH Q2 Deep Dive: Specialty Testing Growth, Hospital Acquisitions, and Margin Expansion
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit of $4.35 per share was 4.5% above analysts’ consensus estimates.
Via StockStory · July 25, 2025
Labcorp Raises Full Year Guidance After Q2 Earnings Beat Wall Street Expectations: Retail Sees Rally To $330stocktwits.com
Via Stocktwits · July 24, 2025
Earnings Scheduled For July 24, 2025benzinga.com
Via Benzinga · July 24, 2025
A Glimpse of Laboratory Corp's Earnings Potentialbenzinga.com
Via Benzinga · July 23, 2025
Labcorp Posts 9.5 Percent Gain in Q2fool.com
Via The Motley Fool · July 24, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 24, 2025
Labcorp (LH) Shares Skyrocket, What You Need To Know
Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) jumped 6.8% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations and raised its full-year financial outlook. The laboratory network operator posted an adjusted EPS of $4.35, which surpassed consensus estimates. Revenue for the quarter increased 9.5% year-over-year to $3.53 billion, driven by growth in both its Diagnostics and Biopharma segments. In a significant show of confidence, Labcorp boosted its full-year 2025 guidance, projecting adjusted earnings per share between $16.05 and $16.50 and revenue growth between 7.5% and 8.6%. The company also noted that it had repurchased $200 million of its common stock during the quarter, further underscoring the strength of its financial position and business performance.
Via StockStory · July 24, 2025
These S&P500 stocks are moving in today's sessionchartmill.com
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · July 24, 2025
Why Is Testing Giant Labcorp Stock Surging On Thursday?benzinga.com
Labcorp beat Q2 earnings and revenue estimates and raised full-year guidance, supported by margin expansion and continued acquisition activity.
Via Benzinga · July 24, 2025
Labcorp (LH) Q2 2025 Earnings Call Transcriptfool.com
Via The Motley Fool · July 24, 2025
RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · July 24, 2025
These S&P500 stocks are gapping in today's sessionchartmill.com
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · July 24, 2025
Labcorp (NYSE:LH) Posts Better-Than-Expected Sales In Q2
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) announced better-than-expected revenue in Q2 CY2025, with sales up 9.5% year on year to $3.53 billion. Its non-GAAP profit of $4.35 per share was 4.5% above analysts’ consensus estimates.
Via StockStory · July 24, 2025
Labcorp Holdings Inc (NYSE:LH) Reports Mixed Q2 2025 Earnings with EPS Beat and Revenue Misschartmill.com
Labcorp (LH) reported mixed Q2 2025 earnings, missing revenue estimates but beating EPS. Shares rose as raised full-year guidance offset concerns.
Via Chartmill · July 24, 2025
Labcorp (LH) Reports Earnings Tomorrow: What To Expect
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings this Thursday morning. Here’s what to expect.
Via StockStory · July 22, 2025
3 Value Stocks with Questionable Fundamentals
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Via StockStory · July 21, 2025
My Favorite Options Trade For This Weekbenzinga.com
With markets typically weakening in August and September, now is a strategic time to consider bearish trades like Labcorp Holdings.
Via Benzinga · July 17, 2025
How Do Investors Really Feel About Labcorp Hldgs?benzinga.com
Via Benzinga · July 17, 2025
A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Looking back on testing & diagnostics services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers.
Via StockStory · July 10, 2025
Demystifying Labcorp Hldgs: Insights From 8 Analyst Reviewsbenzinga.com
Via Benzinga · July 9, 2025
3 Profitable Stocks Walking a Fine Line
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · July 7, 2025
2 S&P 500 Stocks with Promising Prospects and 1 to Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Via StockStory · July 4, 2025